Compliance Corner: 9 US FDA Inspection Questions Answered By Agency Officials, Abbott Quality VP
Executive Summary
Are FDA investigators allowed to fish through a messy filing cabinet for documents? And do low-risk class III recalls play into an inspection? FDA investigator Ben Dastoli from the agency's Cincinnati, Ohio, district office, Cincinnati compliance officer Gina Brackett, and Monica Wilkins, divisional VP of QA/RA for device-maker Abbott Laboratories answer those queries and more from manufacturers.
You may also be interested in...
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.
FDA Slaps High Risk Class I Label On Recall Of COVID-19 Diagnostics Made In Uncontrolled Plant
More than 160,000 of the tests were recalled, including 104,900 COVID Test Kits Nonsterile and 61,500 Clean Catch Urine Kits.